Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice

Alba Granados-Jaén1, Maria Angulo-Ibáñez1, Xavier Rovira-Clavé1

  • 1Celltec-UB, Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona, Spain.

Oncotarget
|October 30, 2016
PubMed

Insights

The absence of MAPK7 delays tumor development in mice lacking ATM, a key DNA damage response protein. This suggests MAPK7 inhibition could partially restore DNA repair and apoptosis, hindering thymic lymphoma growth.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • Ataxia-telangiectasia mutated (ATM) is a crucial kinase regulating cell cycle arrest and DNA repair following DNA damage.
  • Loss-of-function mutations in ATM are linked to increased tumorigenesis.
  • Mitogen-activated protein kinase 7 (MAPK7) is implicated in cancer, often promoting cell survival and growth, but its interaction with tumor suppressors like ATM is unclear.

Purpose of the Study:

  • To investigate the functional relationship between ATM and MAPK7 in the context of DNA damage response and tumorigenesis.
  • To determine if MAPK7 influences tumor development in mice deficient in ATM.
  • To elucidate the impact of MAPK7 absence on thymocyte response to DNA damage and ionizing radiation.

Main Methods:

  • Utilized Atm-/- mice to study spontaneous tumor development.
  • Compared DNA damage response in Atm-/- and Mapk7-/-Atm-/- thymocytes.
  • Assessed DNA damage markers (e.g., phosphorylation of H2AX) and apoptotic responses after ionizing radiation exposure.

Main Results:

  • Absence of MAPK7 significantly delayed death from spontaneous tumors in Atm-/- mice.
  • Mapk7-/-Atm-/- thymocytes showed enhanced DNA damage response, indicated by increased H2AX phosphorylation.
  • These thymocytes also exhibited a restored apoptotic response to ionizing radiation compared to Atm-/- controls.

Conclusions:

  • ATM and MAPK7 play antagonistic roles in the DNA damage response within thymocytes.
  • Lack of MAPK7 can partially restore the DNA damage response in Atm-deficient thymocytes.
  • Inhibiting MAPK7 may represent a therapeutic strategy to impede thymic lymphoma growth in ATM-deficient cancers.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K